Pacific Biomarkers Researchers’ Article Featured in May/June 2011 Issue of IVD Technology Magazine
i-Newswire,
2011-05-27
Article Highlights Kidney Injury Biomarker Program That Could Accelerate Move Toward Personalized Medicine for Kidney Patients
Pacific Biomarkers To Present at 2011 AAPS National Biotechnology Conference in San Francisco on May 17
i-Newswire,
2011-05-12
Amar A. Sethi, MD, PhD, Vice President of Research and Development, and Tonya K. Aggoune, Director of Project Services, are slated to present talks during a symposium on diagnostics.
Pacific Biomarkers, Inc. Awarded Nine Contracts in Early 2011 for Studies in Immunogenicity, Diabetes and Other Areas
i-Newswire,
2011-04-27
The nine contracts are in the areas of immunogenicity, tech transfers, diabetes, ADA, inflammatory and bone markers. The total Value of New Contracts is $920K
Diagnostic and Prognostic Biomarker Database Launched
i-Newswire,
2011-03-08
A database of 29,000 unique biomarkers (for more than 1800 human diseases), which are manually extracted from US patent/WO (PCT) publications and PubMed abstracts.
Pacific Biomarkers To Host Webinar on Latest Developments in Biomarkers for Metabolic Syndrome on March 2
i-Newswire,
2011-02-17
Free webinar will include three PBI Senior Scientists who will outline current state of research
Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development
i-Newswire,
2011-01-31
Ms. DuMond will oversee the Business Development Team and lead PBI’s sales and marketing efforts to secure consistent revenue growth and optimize shareholder value.
Pacific Biomarkers Establishes Scientific Advisory Board
i-Newswire,
2011-01-05
Pacific Biomarkers assembles a strong group of industry experts to guide strategic planning
Pacific Biomarkers, Inc. Among Deloitte’s 2010 Technology Fast 500™
i-Newswire,
2010-10-27
Attributes its 237 Percent Revenue Growth to Broader, Deeper Client Relationships, Expanding Menu of Novel Biomarker Assays, Upgraded Infrastructure, and Pursuit of Central Lab Partnerships
More Studies Are Needed After FDA Issues Warnings About Bisphosphonates Therapy
i-Newswire,
2010-10-19
The Food and Drug Administration recently published a warning to doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs called bisphosphonates.
Biomarkers Global Market to Hit US$26.5bn By 2015 With A CAGR of 20.2% During 2007-15
i-Newswire,
2010-09-20
Industry Experts adds another market research report to its Biotechnology catalogue 'Biomarkers: Discovery Techniques and Applications - A Global Market Overview'
Higher HDL-C Concentrations May Not Always Be a Good Measure of Heart Risk
i-Newswire,
2010-08-03
People with high levels of “good cholesterol,” HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers recently reported.
Pacific Biomarkers Launches New Website
i-Newswire,
2010-07-28
The site, www.PacBio.com, incorporates numerous features to make browsing a more fruitful experience for the Company's current and potential customers and investors.
CCC Diagnostics, Inc to Present Breast Cancer Study Results at Paris Conference
i-Newswire,
2010-06-10
CCC Diagnostics, in present data describing expanded clinical studies of the DirectHit® Panel for Breast Cancer at the 2nd Worldwide Innovative Networking (WIN) in personalized cancer medicine conference on July 7, 2010 in Paris, France.